FDA Proposes Changes to Over-the-Counter Laxative Drug Products

Summary

The Food and Drug Administration (FDA) is proposing amendments to the tentative final monograph for over-the-counter laxative drug products, including new labeling requirements and warnings for oral and rectal sodium phosphates, and a revised time to effect statement for rectal products based on new data.